STOCK TITAN

Teradyne Financials

TER
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Teradyne (TER) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 76 / 100
Financial Profile 76/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability
100

Teradyne has an operating margin of 20.4%, meaning the company retains $20 of operating profit per $100 of revenue. This strong profitability earns a score of 100/100, reflecting efficient cost management and pricing power. This is down from 21.1% the prior year.

Growth
66

Teradyne's revenue grew 13.1% year-over-year to $3.2B, a solid pace of expansion. This earns a growth score of 66/100.

Leverage
93

Teradyne carries a low D/E ratio of 0.50, meaning only $0.50 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 93/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
50

Teradyne's current ratio of 1.75 indicates adequate short-term liquidity, earning a score of 50/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
71

Teradyne converts 14.1% of revenue into free cash flow ($450.4M). This strong cash generation earns a score of 71/100.

Returns
79

Teradyne earns a strong 19.8% return on equity (ROE), meaning it generates $20 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 79/100. This is up from 19.2% the prior year.

Altman Z-Score Safe
23.15

Teradyne scores 23.15, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($49.5B) relative to total liabilities ($1.4B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral
5/9

Teradyne passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
1.22x

For every $1 of reported earnings, Teradyne generates $1.22 in operating cash flow ($674.4M OCF vs $554.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
95.0x

Teradyne earns $95.0 in operating income for every $1 of interest expense ($650.1M vs $6.8M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV
Revenue
$3.2B
YoY+13.1%
5Y CAGR+0.4%
10Y CAGR+6.9%

Teradyne generated $3.2B in revenue in fiscal year 2025. This represents an increase of 13.1% from the prior year.

EBITDA
$778.0M
YoY+9.0%
5Y CAGR-5.9%
10Y CAGR+7.3%

Teradyne's EBITDA was $778.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 9.0% from the prior year.

Free Cash Flow
$450.4M
YoY-5.0%
5Y CAGR-8.0%
10Y CAGR+3.1%

Teradyne generated $450.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 5.0% from the prior year.

Net Income
$554.0M
YoY+2.2%
5Y CAGR-6.7%
10Y CAGR+10.4%

Teradyne reported $554.0M in net income in fiscal year 2025. This represents an increase of 2.2% from the prior year.

EPS (Diluted)
$3.47
YoY+4.5%

Teradyne earned $3.47 per diluted share (EPS) in fiscal year 2025. This represents an increase of 4.5% from the prior year.

Cash & Debt
$293.8M
YoY-46.9%
5Y CAGR-20.3%
10Y CAGR+1.0%

Teradyne held $293.8M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
$0.48
YoY+0.0%

Teradyne paid $0.48 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Shares Outstanding
156M
YoY-3.5%

Teradyne had 156M shares outstanding in fiscal year 2025. This represents a decrease of 3.5% from the prior year.

Gross Margin
58.2%
YoY-0.3pp
5Y CAGR+1.0pp
10Y CAGR+2.4pp

Teradyne's gross margin was 58.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.3 percentage points from the prior year.

Operating Margin
20.4%
YoY-0.7pp
5Y CAGR-9.4pp
10Y CAGR+5.6pp

Teradyne's operating margin was 20.4% in fiscal year 2025, reflecting core business profitability. This is down 0.7 percentage points from the prior year.

Net Margin
17.4%
YoY-1.9pp
5Y CAGR-7.7pp
10Y CAGR+4.8pp

Teradyne's net profit margin was 17.4% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.9 percentage points from the prior year.

Return on Equity
19.8%
YoY+0.6pp
5Y CAGR-15.7pp
10Y CAGR+9.3pp

Teradyne's ROE was 19.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.6 percentage points from the prior year.

R&D Spending
$504.6M
YoY+9.5%
5Y CAGR+6.1%
10Y CAGR+5.6%

Teradyne invested $504.6M in research and development in fiscal year 2025. This represents an increase of 9.5% from the prior year.

Share Buybacks
$702.1M
YoY+253.6%
5Y CAGR+51.3%
10Y CAGR+8.9%

Teradyne spent $702.1M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 253.6% from the prior year.

Capital Expenditures
$224.0M
YoY+13.1%
5Y CAGR+3.9%
10Y CAGR+9.6%

Teradyne invested $224.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 13.1% from the prior year.

TER Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q4'23 Q3'23 Q2'23
Revenue $1.1B+40.8% $769.2M+18.0% $651.8M-4.9% $685.7M-8.9% $752.9M+12.3% $670.6M-4.7% $703.7M+2.8% $684.4M
Cost of Revenue $463.6M+44.9% $319.9M+14.7% $278.8M+3.1% $270.3M-11.5% $305.6M+5.0% $291.1M-4.7% $305.4M+8.3% $281.9M
Gross Profit $619.7M+37.9% $449.3M+20.5% $373.0M-10.2% $415.3M-7.1% $447.3M+17.8% $379.5M-4.7% $398.3M-1.0% $402.5M
R&D Expenses $143.3M+14.8% $124.8M+5.4% $118.4M+0.2% $118.2M-7.9% $128.4M+25.6% $102.2M-2.1% $104.4M-1.2% $105.7M
SG&A Expenses $164.7M-2.6% $169.1M+7.2% $157.8M+0.3% $157.3M+1.0% $155.7M+9.4% $142.3M+2.9% $138.3M-5.1% $145.7M
Operating Income $293.2M+101.8% $145.3M+60.1% $90.7M-24.9% $120.8M-21.3% $153.6M+23.5% $124.3M-13.6% $144.0M+2.9% $139.9M
Interest Expense $3.9M+200.8% $1.3M+62.6% $805K+1.3% $795K+35.2% $588K-27.5% $811K-15.8% $963K-7.8% $1.0M
Income Tax $29.2M+24.9% $23.3M+90.4% $12.3M-15.7% $14.5M+168.9% $5.4M-76.2% $22.8M+40.8% $16.2M-33.6% $24.4M
Net Income $257.2M+115.1% $119.6M+52.6% $78.4M-20.8% $98.9M-32.4% $146.3M+24.9% $117.1M-8.6% $128.1M+6.7% $120.0M
EPS (Diluted) $1.62+116.0% $0.75+53.1% $0.49-19.7% $0.61-31.5% $0.89+23.6% $0.72-7.7% $0.78+6.8% $0.73

TER Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q4'23 Q3'23 Q2'23
Total Assets $4.2B+5.5% $4.0B+5.4% $3.8B+1.5% $3.7B-0.1% $3.7B+6.4% $3.5B+3.4% $3.4B-0.7% $3.4B
Current Assets $1.9B+11.4% $1.8B+10.5% $1.6B-9.8% $1.8B-3.3% $1.8B-16.0% $2.2B+3.0% $2.1B-1.2% $2.1B
Cash & Equivalents $293.8M+7.7% $272.7M-19.6% $339.3M-28.7% $475.6M-14.0% $553.4M-27.0% $757.6M+18.9% $637.0M+3.9% $613.2M
Inventory $379.6M+3.5% $366.8M+4.6% $350.5M+1.6% $345.1M+15.6% $298.5M-3.7% $310.0M-3.9% $322.6M-7.1% $347.3M
Accounts Receivable $786.9M+32.5% $593.8M+37.1% $433.0M-6.0% $460.4M-2.3% $471.4M+11.7% $422.1M-7.4% $455.9M-7.6% $493.2M
Goodwill $521.0M+0.3% $519.5M-0.2% $520.5M+27.2% $409.3M+3.5% $395.4M-4.9% $415.7M+3.6% $401.1M-2.7% $412.1M
Total Liabilities $1.4B+11.3% $1.2B+34.8% $924.6M+1.8% $908.3M+2.1% $889.4M-7.4% $960.9M+3.4% $929.4M-3.2% $960.0M
Current Liabilities $1.1B+12.1% $995.0M+47.3% $675.3M+4.0% $649.1M+3.9% $624.6M-5.4% $660.0M+3.0% $640.7M-4.3% $669.8M
Long-Term Debt $0-100.0% $167.6M N/A N/A $0 N/A $147.3M+1.2% $145.5M
Total Equity $2.8B+2.9% $2.7B-4.2% $2.8B+1.4% $2.8B-0.8% $2.8B+11.6% $2.5B+3.5% $2.4B+0.3% $2.4B
Retained Earnings $744.4M+8.4% $686.8M-17.7% $834.9M-6.5% $893.2M-8.0% $970.8M+37.4% $706.5M+8.0% $653.9M-1.1% $661.5M

TER Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q4'23 Q3'23 Q2'23
Operating Cash Flow $281.6M+474.2% $49.0M-73.1% $182.1M+12.7% $161.6M-42.8% $282.6M+13.6% $248.8M+42.7% $174.3M+22.1% $142.8M
Capital Expenditures $62.9M+34.7% $46.7M-7.4% $50.4M-21.3% $64.0M+11.6% $57.4M+29.4% $44.3M+28.1% $34.6M-11.9% $39.3M
Free Cash Flow $218.8M+9177.0% $2.4M-98.2% $131.7M+34.9% $97.6M-56.6% $225.2M+10.1% $204.4M+46.3% $139.7M+35.0% $103.5M
Investing Cash Flow -$60.9M+9.7% -$67.5M+62.2% -$178.5M-188.9% -$61.8M+8.4% -$67.5M-121.7% -$30.4M-10.5% -$27.5M-2.7% -$26.8M
Financing Cash Flow -$200.8M-320.2% -$47.8M+65.1% -$136.8M+22.6% -$176.8M-8.3% -$163.2M-79.2% -$91.1M+28.6% -$127.6M+17.0% -$153.7M
Dividends Paid $18.7M-1.3% $19.0M-1.1% $19.2M-1.1% $19.4M-0.4% $19.5M+16.0% $16.8M-0.6% $16.9M-0.6% $17.0M
Share Buybacks $183.4M-24.8% $243.8M+107.7% $117.4M-25.4% $157.5M+9.7% $143.5M+182.8% $50.7M-57.2% $118.6M-11.8% $134.5M

TER Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q4'23 Q3'23 Q2'23
Gross Margin 57.2%-1.2pp 58.4%+1.2pp 57.2%-3.3pp 60.6%+1.2pp 59.4%+2.8pp 56.6%0.0pp 56.6%-2.2pp 58.8%
Operating Margin 27.1%+8.2pp 18.9%+5.0pp 13.9%-3.7pp 17.6%-2.8pp 20.4%+1.9pp 18.5%-1.9pp 20.5%+0.0pp 20.4%
Net Margin 23.7%+8.2pp 15.5%+3.5pp 12.0%-2.4pp 14.4%-5.0pp 19.4%+2.0pp 17.5%-0.8pp 18.2%+0.7pp 17.5%
Return on Equity 9.2%+4.8pp 4.4%+1.6pp 2.8%-0.8pp 3.5%-1.7pp 5.2%+0.6pp 4.6%-0.6pp 5.3%+0.3pp 4.9%
Return on Assets 6.2%+3.1pp 3.0%+0.9pp 2.1%-0.6pp 2.7%-1.3pp 3.9%+0.6pp 3.4%-0.4pp 3.8%+0.3pp 3.5%
Current Ratio 1.75-0.0 1.76-0.6 2.35-0.4 2.70-0.2 2.91-0.4 3.280.0 3.28+0.1 3.17
Debt-to-Equity 0.50+0.0 0.46+0.1 0.330.0 0.320.0 0.32-0.1 0.380.0 0.38-0.0 0.39
FCF Margin 20.2%+19.9pp 0.3%-19.9pp 20.2%+6.0pp 14.2%-15.7pp 29.9%-0.6pp 30.5%+10.6pp 19.9%+4.7pp 15.1%

Similar Companies

Frequently Asked Questions

What is Teradyne's annual revenue?

Teradyne (TER) reported $3.2B in total revenue for fiscal year 2025. This represents a 13.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Teradyne's revenue growing?

Teradyne (TER) revenue grew by 13.1% year-over-year, from $2.8B to $3.2B in fiscal year 2025.

Is Teradyne profitable?

Yes, Teradyne (TER) reported a net income of $554.0M in fiscal year 2025, with a net profit margin of 17.4%.

What is Teradyne's earnings per share (EPS)?

Teradyne (TER) reported diluted earnings per share of $3.47 for fiscal year 2025. This represents a 4.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Teradyne's EBITDA?

Teradyne (TER) had EBITDA of $778.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Teradyne's gross margin?

Teradyne (TER) had a gross margin of 58.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Teradyne's operating margin?

Teradyne (TER) had an operating margin of 20.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Teradyne's net profit margin?

Teradyne (TER) had a net profit margin of 17.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Teradyne pay dividends?

Yes, Teradyne (TER) paid $0.48 per share in dividends during fiscal year 2025.

What is Teradyne's return on equity (ROE)?

Teradyne (TER) has a return on equity of 19.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Teradyne's free cash flow?

Teradyne (TER) generated $450.4M in free cash flow during fiscal year 2025. This represents a -5.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Teradyne's operating cash flow?

Teradyne (TER) generated $674.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Teradyne's total assets?

Teradyne (TER) had $4.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Teradyne's capital expenditures?

Teradyne (TER) invested $224.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Teradyne spend on research and development?

Teradyne (TER) invested $504.6M in research and development during fiscal year 2025.

Does Teradyne buy back shares?

Yes, Teradyne (TER) spent $702.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Teradyne have outstanding?

Teradyne (TER) had 156M shares outstanding as of fiscal year 2025.

What is Teradyne's current ratio?

Teradyne (TER) had a current ratio of 1.75 as of fiscal year 2025, which is generally considered healthy.

What is Teradyne's debt-to-equity ratio?

Teradyne (TER) had a debt-to-equity ratio of 0.50 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Teradyne's return on assets (ROA)?

Teradyne (TER) had a return on assets of 13.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Teradyne's Altman Z-Score?

Teradyne (TER) has an Altman Z-Score of 23.15, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Teradyne's Piotroski F-Score?

Teradyne (TER) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Teradyne's earnings high quality?

Teradyne (TER) has an earnings quality ratio of 1.22x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Teradyne cover its interest payments?

Teradyne (TER) has an interest coverage ratio of 95.0x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Teradyne?

Teradyne (TER) scores 76 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.